GALT
Galectin Therapeutics Inc
3.90$
+0.5%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | -85.7% | +0.0% | +3,400.0% | +2.9% | +13.9% | -22.0% | +3.1% | +12.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +55.7% | +16.9% | -23.5% | -44.8% | +15.4% | +140.7% | +32.5% | +33.2% | +1.2% | +13.8% | -60.9% | |
| – | -0.6% | -11.6% | -26.5% | +57.6% | -16.3% | -8.4% | +16.3% | +4.0% | -10.2% | -1.3% | -1.1% | |
| – | +30.1% | +7.0% | -24.4% | -16.3% | -1.2% | +74.5% | +28.7% | +27.1% | -0.7% | +11.5% | -52.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +2,700.0% | -74.1% | +0.0% | +462.1% | +111.2% | +170.3% | +98.4% | +32.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | -41.4% | +778.4% | -5.4% | -806.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.